Cleared Traditional

HEMOCLEAN (K023064) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K023064 · Krd Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2004
Decision
568d
Days
Class 2
Risk

K023064 is an FDA 510(k) clearance for the HEMOCLEAN. Classified as Disinfectant, Dialysate Delivery System (product code NII), Class II - Special Controls.

Submitted by Krd Co., Ltd. (Edina, US). The FDA issued a Cleared decision on April 6, 2004 after a review of 568 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 876.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Krd Co., Ltd. devices

Submission Details

510(k) Number K023064 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2002
Decision Date April 06, 2004
Days to Decision 568 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
439d slower than avg
Panel avg: 129d · This submission: 568d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NII Disinfectant, Dialysate Delivery System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5860
Definition Disinfectant Intended For Reprocessing Dialysate Delivery Systems.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.